Bayer Aktiengesellschaft (FRA:BAYN)
25.96
+0.25 (0.97%)
Last updated: Aug 12, 2025
Heartland Financial USA Revenue
Bayer Aktiengesellschaft had revenue of 10.74B EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17B, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.17B
Revenue Growth
-1.99%
P/S Ratio
0.55
Revenue / Employee
515.59K
Employees
91,864
Market Cap
25.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 123.69B |
Siemens Energy AG | 38.39B |
Rheinmetall AG | 10.67B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 63.03B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Bayer Aktiengesellschaft News
- 5 hours ago - Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology - Business Wire
- 9 hours ago - Bayer inks $1.3 billion deal with Kumquat Biosciences for cancer drug development - Seeking Alpha
- 9 hours ago - Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal - Reuters
- 10 hours ago - Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug - WSJ
- 5 days ago - Bayer A.G. (BAYZF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bayer A.G. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 6 days ago - Bayer drops as core businesses underperform in Q2 - Seeking Alpha
- 6 days ago - Bayer AG Non-GAAP EPS of Є1.23, revenue of Є10.74B; raises FY outlook - Seeking Alpha